Sleep and sleep electroencephalogram in depressed patients treated with phenelzine - PubMed (original) (raw)
Sleep and sleep electroencephalogram in depressed patients treated with phenelzine
H P Landolt et al. Arch Gen Psychiatry. 2001 Mar.
Abstract
Background: The beneficial effect of antidepressant interventions has been proposed to depend on suppression of rapid eye movement (REM) sleep or inhibition of electroencephalographic (EEG) slow-wave activity (SWA) in non-REM sleep. Use of the monoamine oxidase inhibitor phenelzine sulfate can eliminate REM sleep. We studied the relation between REM sleep suppression and antidepressant response and the effect of phenelzine therapy on sleep EEG power spectra.
Methods: Open-labeled prescriptions of 30 to 90 mg of phenelzine were given to 11 patients with major depressive disorder (6 men and 5 women; mean age, 41.4 years); all were physically healthy. Mood, dream recall, sleep, sleep EEG, and ocular and muscular activity during sleep were studied before treatment and during the third and fifth weeks of pharmacotherapy.
Results: Six patients remitted from depression, 2 responded partially, and 3 showed no antidepressant response. Independent from clinical response, REM sleep was dramatically suppressed. On average, only 4.9 minutes of REM sleep was observed in treatment week 5, and it was completely absent in 6 patients. This effect was compensated for by increased stage 2 sleep. In non-REM sleep, EEG power was higher than at baseline between 16.25 and 25 Hz. Slow-wave activity (power within 0.75-4.5 Hz) and the exponential decline of SWA during sleep were not affected.
Conclusions: Antidepressant response to phenelzine treatment does not depend on elimination of REM sleep or inhibition of SWA in non-REM sleep. In depressed patients, REM sleep is regulated independently from non-REM sleep and can be manipulated without altering the dynamics of SWA.
Similar articles
- Different effects of phenelzine treatment on EEG topography in waking and sleep in depressed patients.
Landolt HP, Gillin JC. Landolt HP, et al. Neuropsychopharmacology. 2002 Sep;27(3):462-9. doi: 10.1016/S0893-133X(02)00322-6. Neuropsychopharmacology. 2002. PMID: 12225703 Clinical Trial. - Effect of chronic phenelzine treatment on REM sleep: report of three patients.
Landolt HP, de Boer LP. Landolt HP, et al. Neuropsychopharmacology. 2001 Nov;25(5 Suppl):S63-7. doi: 10.1016/S0893-133X(01)00321-9. Neuropsychopharmacology. 2001. PMID: 11682276 - Rapid tryptophan depletion reverses phenelzine-induced suppression of REM sleep.
Landolt HP, Kelsoe JR, Rapaport MH, Gillin JC. Landolt HP, et al. J Sleep Res. 2003 Mar;12(1):13-8. doi: 10.1046/j.1365-2869.2003.00336.x. J Sleep Res. 2003. PMID: 12603782 Clinical Trial. - Dreaming under antidepressants: a systematic review on evidence in depressive patients and healthy volunteers.
Tribl GG, Wetter TC, Schredl M. Tribl GG, et al. Sleep Med Rev. 2013 Apr;17(2):133-42. doi: 10.1016/j.smrv.2012.05.001. Epub 2012 Jul 15. Sleep Med Rev. 2013. PMID: 22800769 Review. - Sleep, natural and unnatural.
Oswald I. Oswald I. Proc R Soc Med. 1969 Sep;62(9):901-3. Proc R Soc Med. 1969. PMID: 4310658 Free PMC article. Review. No abstract available.
Cited by
- Association of Sleep Architecture and Physiology with Depressive Disorder and Antidepressants Treatment.
Hutka P, Krivosova M, Muchova Z, Tonhajzerova I, Hamrakova A, Mlyncekova Z, Mokry J, Ondrejka I. Hutka P, et al. Int J Mol Sci. 2021 Jan 29;22(3):1333. doi: 10.3390/ijms22031333. Int J Mol Sci. 2021. PMID: 33572767 Free PMC article. Review. - The Functional Role of Dreaming in Emotional Processes.
Scarpelli S, Bartolacci C, D'Atri A, Gorgoni M, De Gennaro L. Scarpelli S, et al. Front Psychol. 2019 Mar 15;10:459. doi: 10.3389/fpsyg.2019.00459. eCollection 2019. Front Psychol. 2019. PMID: 30930809 Free PMC article. Review. - Effects of COMT genotype and tolcapone on lapses of sustained attention after sleep deprivation in healthy young men.
Valomon A, Holst SC, Borrello A, Weigend S, Müller T, Berger W, Sommerauer M, Baumann CR, Landolt HP. Valomon A, et al. Neuropsychopharmacology. 2018 Jun;43(7):1599-1607. doi: 10.1038/s41386-018-0018-8. Epub 2018 Feb 5. Neuropsychopharmacology. 2018. PMID: 29472644 Free PMC article. Clinical Trial. - Depression and sleep: pathophysiology and treatment.
Thase ME. Thase ME. Dialogues Clin Neurosci. 2006;8(2):217-26. doi: 10.31887/DCNS.2006.8.2/mthase. Dialogues Clin Neurosci. 2006. PMID: 16889107 Free PMC article. Review. - The Neurobiological Mechanisms and Treatments of REM Sleep Disturbances in Depression.
Wang YQ, Li R, Zhang MQ, Zhang Z, Qu WM, Huang ZL. Wang YQ, et al. Curr Neuropharmacol. 2015;13(4):543-53. doi: 10.2174/1570159x13666150310002540. Curr Neuropharmacol. 2015. PMID: 26412074 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources